FDA releases guidance to help combat pharmaceutical counterfeiting within supply chain
As pharmaceutical supply chains expand into India, China and other emerging economies, safety protocols become increasingly difficult to enforce. A recent Financial Times report shows, for example, governments are at times complicit with stonewalling audits that would threaten suppliers within the profitable industry…